On Oct. 23, 2024, the University of Rochester announced that the Saunders Foundation, led by University Trustee Emeritus…
On Jun. 12, 2024, scientists at Weill Cornell Medicine in New York City reported that just a few…
On Nov. 10, 2023, surgeons in New York announced they had performed the first-ever whole-eye transplant in a…
On Jul. 28, 2023, in a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Healthï¾’s…
On Jul. 21, 2022, The New York State Department of Health and the Rockland County Department of Health…
On Feb. 19, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service (APHIS) confirmed the…
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
On Aug. 30, 2021, the United Nations announced the global phase-out of leaded fuel, a milestone for multilateralism,…
On Mar. 10, 2021, the U.S. Department of Defense (DOD) announced that it had identified additional personnel authorized…
On Feb. 23, 2021, the NIH announced that a randomized, placebo-controlled Phase 1 clinical trial of two monoclonal…
On Jan. 26, 2021, NIH researchers announced that a new database to collect information from clinicians about COVID-19-related…
On Nov. 17, 2020, Celdara Medical announced that the NIH had awarded a two-year Small Business Innovation Research…
On Nov. 8, 2020, research from the U.S. had shown that white-tailed deer were being infected with SARS-CoV-2,…
On Oct. 9, 2020, OPKO Health subsidiary BioReference Labs, New York City, the Department of Health, New York…
On Sept. 2, 2020, BioReference Laboratories, an OPKO Health company, began testing New York City principals, teachers and…
On Aug. 27, 2020, Todos Medical announced it had entered into a sales agreement with a New York-based…
On Aug. 3, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On Jul. 29, 2020, Constant Therapeutics announced that its peptide drug TXA127, a pharmaceutical formulation of the natural…
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
On Jun. 19, 2020, the COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests…
On Jun. 18, 2020, researchers at Montefiore Health System and Albert Einstein College of Medicine, in collaboration with…
On Jun. 2, 2020, the USDA announced the first confirmed case of SARS-CoV-2 (the virus that causes COVID-19)…
On May 26, 2020, Montefiore Health System and Albert Einstein College of Medicine began the next stage of…
On May 19, 2020, Bio-Techne and the Mount Sinai Health System in New York, through its commercial affiliate…
On May 8, 2020, BioReference Laboratories, an OPKO Health company, announced the launch of COVID-19 antibody screening available…
On May 7, 2020, a study of nearly 1,400 patients with moderate to severe COVID-19 disease at a…
On Apr. 30, 2020, the research community reacted with alarm and anger to the National Institutes of Health’s…
On Apr. 27, 2020, Atossa Therapeutics announced that it had contracted with NYC Health + Hospitals/Metropolitan in New…
On Apr. 24, 2020, Mesoblast announced an 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory…
On Apr. 23, 2020, Western New York healthcare and medical research leaders joined forces in an effort to…